title: Periocular epithelioid hemangioma: response to bevacizumab and vascular pathogenesis.
authors.affiliation: Department of Ophthalmology, University of Michigan, Ann Arbor, MI 48105, USA.
authors.forename: Alon
authors.initials: A
authors.lastname: Kahana
authors.forename: Brian J
authors.initials: BJ
authors.lastname: Lee
authors.forename: Andrew
authors.initials: A
authors.lastname: Flint
authors.forename: Victor M
authors.initials: VM
authors.lastname: Elner
mesh_terms: D020533:Angiogenesis Inhibitors / Q000008:administration & dosage / Q000627:therapeutic use*; D000796:Angiolymphoid Hyperplasia with Eosinophilia / Q000175:diagnosis / Q000188:drug therapy* / Q000209:etiology; D061067:Antibodies, Monoclonal, Humanized / Q000008:administration & dosage / Q000627:therapeutic use*; D000068258:Bevacizumab; D001808:Blood Vessels / Q000473:pathology; D003646:Debridement; D005141:Eyelid Diseases / Q000175:diagnosis / Q000188:drug therapy* / Q000209:etiology; D005260:Female; D006801:Humans; D015552:Injections, Intralesional; D008279:Magnetic Resonance Imaging; D009916:Orbital Diseases / Q000175:diagnosis / Q000188:drug therapy* / Q000209:etiology; D016491:Peripheral Vascular Diseases / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology; D012189:Retrospective Studies; D014057:Tomography, X-Ray Computed; D042461:Vascular Endothelial Growth Factor A / Q000037:antagonists & inhibitors; D055815:Young Adult
chemical_list: D020533:Angiogenesis Inhibitors; D061067:Antibodies, Monoclonal, Humanized; C467484:VEGFA protein, human; D042461:Vascular Endothelial Growth Factor A; D000068258:Bevacizumab